Position in VCEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$45,210,024
+$9,862,563 QoQ
Shares Held
1,016,184
-7.5% QoQ
Ownership
1.98%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 317 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 41%
Shared 0%
None 59%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. VCEL ranks #54 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in VCEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $45,210,024 | 1,016,184 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $35,347,461 | 1,098,771 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $33,057,537 | 918,010 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $16,602,562 | 527,568 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $18,646,599 | 438,228 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $15,912,737 | 356,628 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $7,675,866 | 139,790 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,972,838 | 141,369 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,252,890 | 136,288 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $7,118,883 | 136,849 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,632,787 | 73,934 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,481,687 | 103,869 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,899,912 | 77,187 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $5,726,780 | 195,320 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $3,137,514 | 119,116 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $2,242,415 | 96,656 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,539,526 | 61,141 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,656,669 | 69,510 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,132,629 | 105,156 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $3,782,535 | 77,511 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,535,453 | 67,342 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $3,863,334 | 69,547 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $585,359 | 18,956 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $413,513 | 22,316 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $368,204 | 26,643 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $364,635 | 39,764 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||